PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus

In the “big picture” perspective of the recent years that we have described in Brazil, Spain, Portugal and Puerto Rico there are some similarities and important differences,

Thus, the disease progression CM describes the associa- tions between the demographic characteristics of patients, the central attributes of COPD representing disease progression

The aim of this work is to search for immunological genetic markers that can explain the natural evolution of hepatitis C virus infection in the patient coinfected with the

Therefore, we performed a candidate gene study to investigate single-nucleotide polymorphisms (SNPs) that can predict the response to anti-TNF drugs in Caucasian

SFKs participate in the development and progression of several human cancers, including breast cancer. To investigate the role of c-Src in the first steps that lead to metastasis,

Prospective observational study evaluating the association of 124 polymorphisms with the response to adalimumab or infliximab (PASI75) in patients with moderate-to-severe

Therefore, we analyzed 173 single-nucleotide polymorphisms in genes associated with psoriasis and other autoimmune diseases in patients with moderate-to-severe plaque psoriasis type

Although we did not observe a significant association of CD40-CD154 gene variants with the development of CV events, an ANCOVA model adjusted for sex, age at the time of